This inventor holds 13 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Bayer Pharmaceuticals Corporation, Bayer Healthcare LLC, Smithkline Beecham Corporation. Active years: 2004-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 71 
4 out of 790 
1 out of 2,198 Years Active: 2004-2014
Title: Yamin Wang: Innovator in Pharmaceutical Research
Introduction
Yamin Wang, located in Sandy Hook, CT, is a distinguished inventor with a remarkable portfolio of 13 patents. His work primarily focuses on developing innovative pharmaceutical compounds that aim to address various health issues, including hyper-proliferative disorders and metabolic diseases.
Latest Patents
Among his latest achievements, Wang has patented **Substituted 4-amino-pyrrolotriazine derivatives**, which promise to be effective in the treatment of hyper-proliferative disorders and diseases associated with angiogenesis. This invention introduces novel pyrrolotriazine compounds and their pharmaceutical compositions, highlighting their potential for preventing and treating significant health conditions.
Another notable patent from Wang is centered on **Indane acetic acid derivatives** and their application as pharmaceutical agents. This invention details novel derivatives that may be beneficial in treating diseases such as diabetes, obesity, hyperlipidemia, and atherosclerosis. The patent also encompasses methods for preparing these indane acetic acid derivatives, emphasizing his innovative approach to pharmaceutical development.
Career Highlights
Yamin Wang’s career includes significant contributions while working with Bayer Pharmaceuticals Corporation and Bayer Healthcare LLC. These experiences have allowed him to collaborate on various projects and advance his research in the pharmaceutical field.
Collaborations
In his journey as an inventor, Wang has collaborated with esteemed professionals, including William H. Bullock and Derek B. Lowe. These collaborations have enhanced the depth and impact of his research, fostering innovative developments in medicinal chemistry.
Conclusion
Yamin Wang stands out as a pivotal figure in pharmaceutical innovation. His 13 patents showcase his commitment to advancing the field of medicine through novel compounds and therapies. As he continues to build on his work, the medical community eagerly anticipates the impact of his innovative contributions on health and disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile